GIP
BMY icon

Greatmark Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Greatmark Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,941
Closed -$271K – 89
2015
Q4 		$271K Hold
3,941
– – 0.12% 71
2015
Q3 		$233K Hold
3,941
– – 0.11% 75
2015
Q2 		$262K Buy
+3,941
New +$260K 0.11% 71

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Greatmark Investment Partners's BMY Position: Q1 2016 in Review

Greatmark Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 3,941 shares — an estimated $271K sold.

Greatmark Investment Partners first reported a position in BMY in Q2 2015 and held it in 3 quarters. The position peaked at $271K in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Greatmark Investment Partners reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
  • Greatmark Investment Partners sold 3,941 Bristol-Myers Squibb shares in Q1 2016, an estimated $271K.
  • Greatmark Investment Partners first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 3 quarters.
  • Greatmark Investment Partners's Bristol-Myers Squibb position peaked at $271K in Q4 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Greatmark Investment Partners's 13F filing for Q1 2016, filed 29 Apr 2016.